Skip to content
Disclosery

Triumph Capital Management: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Triumph Capital Management on GSK, newest first. How the timeline and the estimate are built.

Triumph Capital Management held 983 GSK shares at 2026-06-30 per its 13F-HR filed 2026-07-21.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 983 shares
    Change vs previous 13F -34 shares

    0.01% of the 13F portfolio, value $51,529.

    13F-HR 0001730765-26-000006 filed by Triumph Capital Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,017 shares
    Change vs previous 13F +55 shares

    0.01% of the 13F portfolio, value $56,613.

    13F-HR 0001730765-26-000004 filed by Triumph Capital Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 962 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $47,176.

    13F-HR 0001730765-26-000002 filed by Triumph Capital Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).